Treatment of attention-deficit/hyperactivity disorder: overview of the evidence - Test2 - elhamkhani - TriplyDB

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

http://www.wikidata.org/entity/Q28254103

about

Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder ADHD drugs and serious cardiovascular events in children and young adults ADHD in Children Onset of Efficacy of Long-Acting Psychostimulants in Pediatric Attention-Deficit/Hyperactivity Disorder Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults Natural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination Therapy Nonpharmacological Interventions for Children with Attention Deficit Hyperactivity Disorder in India: A Comprehensive and Comparative Research Update.Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence Sweat it out? The effects of physical exercise on cognition and behavior in children and adults with ADHD: a systematic literature review Auditory Processing Assessment in Children with Attention Deficit Hyperactivity Disorder: An Open Study Examining Methylphenidate Effects.Update on optimal use of lisdexamfetamine in the treatment of ADHD.Chiropractic care for paediatric and adolescent Attention-Deficit/Hyperactivity Disorder: A systematic review Reinforcement, dopamine and rodent models in drug development for ADHD The influence of task environment and health literacy on the quality of parent-reported ADHD data Safety of non-therapeutic atomoxetine exposures--a national poison data system study.Utilization of Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder among 5.4 Million Children Using Population-Based Longitudinal Data.What is attention-deficit hyperactivity disorder (ADHD)?Preferences for treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): a discrete choice experiment Caloric and nutrient intake in children with attention deficit hyperactivity disorder treated with extended-release methylphenidate: analysis of a cross-sectional nutrition survey Acute psychosis with attention-deficit/hyperactivity disorder and oppositional-defiant disorder comorbidities Health literacy and task environment influence parents' burden for data entry on child-specific health information: randomized controlled trial.Chiropractic diagnosis and management of non-musculoskeletal conditions in children and adolescents.Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial Cognitive training programs for childhood cancer patients and survivors: A critical review and future directions.Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD ADHD, stimulant treatment, and growth: a longitudinal study.Long-term efficacy of methylphenidate in enhancing attention regulation, social skills, and academic abilities of childhood cancer survivors Executive function deficits in children with attention-deficit/hyperactivity disorder and improvement with lisdexamfetamine dimesylate in an open-label study.Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East Asia.Traditional Oriental Herbal Medicine for Children and Adolescents with ADHD: A Systematic Review.Serotonin (5-HT) precursor loading with 5-hydroxy-l-tryptophan (5-HTP) reduces locomotor activation produced by (+)-amphetamine in the rat.Central nervous system stimulants for secondary attention deficit-hyperactivity disorder after paediatric traumatic brain injury: a rationale and protocol for single patient (n-of-1) multiple cross-over trials.Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial.Methylphenidate and μ opioid receptor interactions: a pharmacological target for prevention of stimulant abuse.Mutation of Elfn1 in mice causes seizures and hyperactivity.Methylphenidate increases cigarette smoking in participants with ADHD.Efficacy and safety of modafinil film-coated tablets in children and adolescents with or without prior stimulant treatment for attention-deficit/hyperactivity disorder: pooled analysis of 3 randomized, double-blind, placebo-controlled studies.Animal models to guide clinical drug development in ADHD: lost in translation?

P2860

Q22241421-1D1ACD87-EC3D-4F27-B301-7EBC1E9E2B71 Q22241830-9C6AD7BE-ED69-4ED0-A37B-F7DED8FA8D19 Q22250876-B0FEE941-2B95-4550-9540-7185598A8303 Q22305481-56E88223-E2FC-425F-9087-0742554F8CCC Q24647676-AB5E2294-36A4-4AB7-A5F7-AF9A26EBAD2A Q24658208-2444D4B2-E03F-4708-B5D7-EC780DFEE76D Q26471999-7C496967-D097-426D-A972-75D0559C6857 Q26766330-960318F3-8473-44A1-AE32-4C9CD50D7F86 Q28073259-EFE802C1-885D-43AD-B7D0-055D21594A03 Q28596811-8A9D2740-636F-4AD4-AEAC-5B2458F5477C Q30363399-AF6F8128-AD77-4003-AF9A-D0DF53CD77C5 Q30366320-338219EE-F847-4949-8A76-870C2C33B91B Q30418053-640D7380-6D23-4D61-AF40-E8DA094E81C1 Q30495118-5C52D6EB-63C9-4E57-8509-AE223F43E0DA Q30524906-8E1372A1-BEA4-428E-9E92-9C295C3E182E Q30619849-D53B2915-2BFF-4720-869E-5CD5C6D820B3 Q30655656-CE503A66-B5A1-49BF-AFB2-A2B97BEFAA7F Q31146596-FC34DFDB-A743-42AC-B7C3-D0345EAE1696 Q33231807-A7B38DCE-FBA1-4D58-82E1-872FD24BC9D6 Q33493217-0573CD05-8AFD-4E3F-AC82-F432DAAACD3A Q33576518-5565B902-6FED-4E0D-873F-D2A87D42F100 Q33744211-9BF28406-FAA3-4FF6-9C94-02114DDBA163 Q33804722-8D0F3892-C17D-42D9-8A38-38F7C6A9B546 Q33939712-06A75951-C615-4F34-93B1-2031307664C3 Q33988480-2AC60950-9B5E-4695-8257-566DA8C1B8C7 Q34044232-8A3F984D-C9A4-4D97-ACB4-DD6D8154CD93 Q34205490-2C5C92D9-ED2B-436E-A64B-0806B9FBD5FD Q34263102-7FA7CA32-BC33-4097-A533-97F5BD11AAFF Q34334936-22981A7D-7BA7-42E5-BEA1-BFABE9C5FB47 Q34421050-CF747D13-80F3-420A-9FCB-AB8B1ABD291B Q34446828-1B336262-2AAE-4CE0-865C-58C59AE8B530 Q34560732-A08D09FA-1B0A-44E7-BBD2-27717C6B810E Q34605239-FD3DE336-2749-4C6B-99C5-C1F8932C76BB Q34741859-65571A16-5D06-4410-8153-891A9738EBE4 Q34987236-63D37097-10DA-407F-86E5-8A3122AD7917 Q35016913-E7335CCC-6F23-4594-A9F8-FA1DD7DC46BC Q35060316-E0BF15BC-82F7-49DF-947A-20C71ECCC97B Q35293009-CE1CF471-23B6-442D-AAE9-291799E1DEB9 Q35574482-C9495E47-4AAB-4749-BF99-5C00EBA334D0 Q35589937-71FC0C79-8830-4993-A2C9-A18B04CB1CC1

P2860

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

http://www.wikidata.org/entity/Q28254103

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

@ast

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

@en

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

@nl

type

label

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

@ast

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

@en

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

@nl

prefLabel

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

@ast

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

@en

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

@nl

P1433

Q28254103-03DF98E9-F6E4-4E0F-AFC3-5296BF32D58A

P1476

Q28254103-3B2CDF07-A722-465E-A847-526E01AA5459

P2093

Q28254103-195C3856-BBEC-42DE-8054-F4C7B982FB8E

Q28254103-25D97CC3-392F-4009-9D7B-8DDA31A7FF52

Q28254103-78836D4C-5C1B-4495-858D-8C53F9524773

Q28254103-A9515FE2-0053-4D92-9AF6-5A78FD9C5D51

Q28254103-AC9DF54E-207B-4424-A5C5-F3A4C9E50A91

Q28254103-C04670E2-3300-47C7-B380-2B019453E225

Q28254103-C1DE650B-55C5-48A6-BAB8-23148BC89D8B

P304

Q28254103-3F38B0B5-052E-445C-9B1D-59091CD41365

P31

Q28254103-20DA4623-FBE0-4FAB-BAD8-E7FF3CB6545D

P3181

Q28254103-B49140CA-C0C3-4B57-82CA-A5702B8F573B

P356

Q28254103-B64A4FC5-4B11-4E31-A931-99FC84BF8C07

P407

Q28254103-5F14F58B-1E13-4D23-84DD-FA877361E3FE

P433

Q28254103-B7651CBD-9731-42A4-9A95-4550AB999B2D

P478

Q28254103-4E422CEC-E15A-449F-842E-0608CB4292FD

P50

Q28254103-5E13FA98-46B0-4002-863D-4FBCA10DDFD3

Q28254103-927105D7-AA8F-4AE3-B99F-3CEF4CE62E71

Q28254103-D76CB3E6-A172-4A0B-A8CA-AE9C5B95B8C5

P577

Q28254103-F0E9800F-4339-4631-83E1-4B9C5BAB5452

P698

Q28254103-502FBC58-CDB0-4887-8A58-8C965A7BD191

P921

Q28254103-6E731623-8545-42B7-B518-059F909D9AF2

Q28254103-CA53D611-CE4A-4BE0-AFC7-92F9B16C029B

P3181

P356

P1433

P1476

Treatment of attention-deficit/hyperactivity disorder: overview of the evidence

@en

P2093

American Academy of Pediatrics Committee on Quality Improvement

http://www.w3.org/2001/XMLSchema#string

American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder

http://www.w3.org/2001/XMLSchema#string

Karen Pierce

http://www.w3.org/2001/XMLSchema#string

Mark L Wolraich

http://www.w3.org/2001/XMLSchema#string

Martin T Stein

http://www.w3.org/2001/XMLSchema#string

Robert W Amler

http://www.w3.org/2001/XMLSchema#string

Wendy S Freeman

http://www.w3.org/2001/XMLSchema#string

P304

e749-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

854437

http://www.w3.org/2001/XMLSchema#string

P356

10.1542/PEDS.2004-2560

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

James M. Perrin

Heidi M Feldman

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15930203

http://www.w3.org/2001/XMLSchema#string

P921

attention deficit hyperactivity disorder